Friday, August 1, 2025
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology

July 11, 2025
in GlobeNewswire, Web3
Reading Time: 5 mins read
5
SHARES
243
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

BLUE BELL, Pa., July 10, 2025 (GLOBE NEWSWIRE) — Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud to announce its co-authorship of a groundbreaking study on Hereditary Hemorrhagic Telangiectasia (HHT), recently published in the American Journal of Hematology.

The study, “Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia”, is the largest study of patients with HHT ever conducted, including over 24,000 patients living with this rare, inherited bleeding disorder. The research reveals that, within this sample, the direct medical costs for HHT exceeded $450 million annually in the United States, driven primarily by the treatment of bleeding-related complications, including anemia.

“By leveraging Komodo Health’s Healthcare Map®, which includes data from over 330 million US patients, we have been able to characterize a rare disease whose natural history and burden have never been well-defined or fully understood,” said Tracy J. Mayne, PhD, Senior Vice President of Regulatory and Life Science Research at Slipstream. “We now know that nearly 60% of patients diagnosed with HHT have bleeding so severe that it causes anemia, and a significant portion of those patients receive frequent IV iron and/or red cell transfusions. The burden for both patients and the healthcare system is enormous, with significant implications for advocacy and drug development.”

The research team, which includes collaborators from Massachusetts General Hospital, Cure HHT, and Diagonal Therapeutics, utilized Komodo real-world claims data to evaluate the economic burden of disease in a cohort of more than 24,000 patients in 2022 and 2023.

Key findings from the publication include:

  • Per patient per year (PPPY) costs for people living with HHT are comparable to or surpass those of other rare and resource-intensive diseases.
  • Bleeding and its consequences were identified as the primary drivers of healthcare costs.
    • Mean PPPY costs for all HHT patients were >$19,000 across 2022 and 2023, about 20% higher than those for sickle cell disease.
    • For HHT patients with anemia, the mean PPPY costs were approximately $27,000
    • Patients with HHT receiving hematologic support (iron infusions and/or red blood cell transfusions) had mean PPPY costs of approximately $40,000
    • HHT patients with anemia, while accounting for nearly 60% of the HHT patient population, were responsible for approximately 80% of the direct medical costs.
  • Notably, the prevalence of liver transplantation among HHT patients, arising from complications of liver AVMs, was 40 times greater than in the general U.S. population.

“Slipstream was founded on the belief that technology should empower the life sciences industry to move faster, work smarter, and operate more efficiently,” said Brandon McKay, Chief Executive Officer at Slipstream. “Studies like this one validate how the right data, paired with the right expertise, can redefine what is possible in healthcare. This collaboration is exactly the kind of work we strive to do partnering with innovators across the ecosystem to unlock the power of real-world data and digital platforms. Our goal is always to accelerate impact where it matters most, improving patient outcomes.”

This landmark study provides critical evidence of the high level of unmet need for patients living with HHT, who have few treatment options and no approved drugs that modify disease or are able to slow or halt progression. This study strengthens the case for future therapeutic development and is an example of the value real-world evidence and the Komodo health database bring to the rare disease space.

The full article is available online through the American Journal of Hematology: https://doi.org/10.1002/ajh.27756

About Slipstream
Slipstream is a trusted technology partner exclusively serving the Life Sciences industry. Our global team brings deep domain expertise and pragmatic, end-to-end solutions that simplify complex challenges across the entire product lifecycle. We deliver with speed, compliance, and foresight— empowering clients to accelerate research, optimize time to market, and improve patient outcomes, ensuring technology keeps pace with their life-changing mission.

About Slipstream’s Digital CRO Practice

Slipstream’s Digital CRO Practice is advancing drug development by utilizing real-world data and current data science to create external/synthetic controls and real-world/placebo hybrids as primary basis of approval for drugs developed to treat rare diseases. As a market leader in digital pharmaceutical digital platforms, Slipstream combines deep therapeutic expertise with real-world regulatory experience and industry-leading technology to help rare disease companies achieve approval faster and at significantly reduced cost. Using large national databases, Slipstream also assists in site identification and recruitment for rare disease trials.

Media Contact:
Isabella Canuso

Sr. Marketing Manager
Slipstream
Isabella.canuso@slipstream-it.com
(609)682-1080
http://www.slipstream-it.com

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.

ShareTweet1ShareSendShare2
Previous Post

OTSAW Announces Official Empanelment as Certified System Integrator for Singapore’s RoMi H Robotics Middleware Framework

Next Post

Hexaware and Abluva Join Forces to Deliver Secure Agentic AI Solutions for the Life Sciences Industry

Related Posts

Merto Software Solutions Powers Ahead as a Leading Force in Bespoke Software for UK Businesses

Windsor, UK - 31 July, 2025 - Merto Software Solutions, a fast-growing UK-based software development company, is making waves in the digital transformation space with its tailored approach to building powerful, user-friendly software for SMEs and mid-sized enterprises.Founded with the belief that software should work around the business, not the...

Read moreDetails

Fintradix Announces Major Upgrade to Meet Rising Volume in European Crypto Markets

London, UK , July 31, 2025 (GLOBE NEWSWIRE) -- Fintradix, a leading crypto trading platform, has unveiled a significant upgrade to its trading infrastructure in response to the rapidly increasing volume of cryptocurrency transactions across European markets. This strategic enhancement is designed to provide traders with improved execution speed, seamless...

Read moreDetails

Acceleware Ltd. Announces Closing of First Tranche of Non-Brokered Private Placement

CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine regeneration (for carbon capture and other applications), and enhanced oil production, announces that the Company closed the...

Read moreDetails

Geotab Unveils Advanced Cold Chain Solution with New Hardware and Enhanced Software

SINGAPORE, Aug. 01, 2025 (GLOBE NEWSWIRE) -- In Southeast Asia, where up to 90% of food loss occurs during transportation due to poor cold chain infrastructure, tackling waste within the temperature-controlled supply chain is critical. Geotab Inc. ("Geotab"), a global leader in connected vehicle and asset solutions, today announced a significant...

Read moreDetails

CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity platform, is participating in the Centers for Medicare & Medicaid Services (CMS) Health Tech Ecosystem initiative, a nationwide effort to deliver a more connected, patient-centered healthcare system. CLEAR was proud to stand alongside government, healthcare, and...

Read moreDetails

HRC WORLD PLC: AUDITED ANNUAL RESULTS TO 31 MARCH 2025

HRC WORLD PLC NASDAQ FIRST NORTH, COPENHAGENTICKER: HRCISIN: GB00BZ3CDY20 31 July 2025 AUDITED ANNUAL RESULTS TO 31 MARCH 2025 The Board of Directors of HRC World Plc (the “Company”), has approved and subsequently are pleased to present its audited financial results for the financial year ended 31 March 2025. The...

Read moreDetails

Altai Announces Filing of Meeting Materials for Special Meeting of Shareholders

TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Altai Resources Inc. (TSXV: ATI) (“Altai” or the “Company”) announced today that it has filed a management information circular (the “Circular”) and related meeting materials (together with the Circular, the “Meeting Materials”) in connection with a special meeting (the “Meeting”) of shareholders of...

Read moreDetails

CORRECTION: Coralogix Contributes MongoDB Compatibility to OpenTelemetry eBPF Auto-Instrumentation

BOSTON, July 31, 2025 (GLOBE NEWSWIRE) -- In our press release dated July 23rd, 2025, titled “Coralogix Donates eBPF Auto-Instrumentation to the OpenTelemetry Community”, despite our rigorous review process for all public content, we included some inaccuracies that we wish to correct. The original release stated that we contributed eBPF...

Read moreDetails

Early Education Machine Market is Going to Boom Worldwide | Major Giants Lingokids, BYJU’S, PlayShifu

Early Education Machine HTF MI recently introduced Global Early Education Machine Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2025-2033). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is...

Read moreDetails

ASSEMBLY APPOINTS ALAP GHOSH AS FIRST CEO OF INDIA

Former Google India executive to lead unified national operations across Mumbai and Bangalore. MUMBAI, India, July 31, 2025 /PRNewswire/ -- Assembly, a global omnichannel media agency within the Stagwell network, today announced the appointment of Alap Ghosh as its first-ever CEO for India. Based in Mumbai, Ghosh will officially step into...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Unifying Blockchain Ecosystems: 2024 Guide to Cross-Chain Interoperability

    83 shares
    Share 33 Tweet 21
  • Top Cross-Chain DeFi Solutions to Watch by 2025

    46 shares
    Share 18 Tweet 12
  • Discover 2025’s Top 5 Promising Low-Cap Crypto Gems

    64 shares
    Share 26 Tweet 16
  • Top 5 Wallets for Seamless Multi-Chain Trading in 2025

    42 shares
    Share 17 Tweet 11
  • Discover the Best Metaverse Crypto Projects and Virtual Worlds 2025

    44 shares
    Share 18 Tweet 11
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

Web 3.0 and AI Summit 2025

2025-09-11
Frankfurt
Summit

Latest on Web3Wire

  • Merto Software Solutions Powers Ahead as a Leading Force in Bespoke Software for UK Businesses
  • Fintradix Announces Major Upgrade to Meet Rising Volume in European Crypto Markets
  • Acceleware Ltd. Announces Closing of First Tranche of Non-Brokered Private Placement
  • Geotab Unveils Advanced Cold Chain Solution with New Hardware and Enhanced Software
  • CLEAR Joins White House and CMS Effort to Power an Interoperable, Secure Digital Health Ecosystem

RSS Latest on Block3Wire

  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age
  • Cathedra Bitcoin Announces Leasing of 2.5-MW Bitcoin Mining Facility
  • Global Web3 Payments Leader, Banxa, Announces Integration With Metis to Usher In Next Wave of Cryptocurrency Users
  • Dexalot Launches First Hybrid DeFi Subnet on Avalanche

RSS Latest on Meta3Wire

  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
  • MetatronAI.com Unveils Revolutionary AI-Chat Features and Interface Upgrades
  • Purely.website – Disruptive new platform combats rising web hosting costs
  • WEMADE and Metagravity Sign Strategic Alliance MOU to Collaborate on Blockchain Games for the Metaverse
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Whitepaper | Tokenomics

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Media Portfolio: Block3Wire | Meta3Wire

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!
Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.